Skip to main content
SpringerLink
Log in

HT-NIPT for fetal RhD genotype cost saving

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 British pounds

Reference

  • Saramago P, et al. High-throughput, non-invasive prenatal testing for fetal RHD genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis. BJOG: An International Journal of Obstetrics and Gynaecology : 7 Feb 2018. Available from: URL: http://doi.org/10.1111/1471-0528.15152

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HT-NIPT for fetal RhD genotype cost saving. PharmacoEcon Outcomes News 797, 20 (2018). https://doi.org/10.1007/s40274-018-4729-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4729-1

Search

Navigation